Synthezyme's technology uses certain yeast strains to convert natural biobased lipids to industrial monomers and surfactants. SyntheZyme is a privately-held sustainable chemical company. SyntheZyme uses the understanding of biocatalysis to replace petrochemical based industrial chemicals with biobased and biodegradable alternatives. Focusing on chemicals for plastics, pesticides, cosmetics and personal care product ingredients. SyntheZyme is developing yeast strains for conversion of natural biobased lipids to industrial monomers and surfactants. Metabolic pathway and protein engineering allow the targeting of chosen feedstocks and end products. Fermentation and downstream processing tailored to these proprietary yeast strains enables high productivity and end-product purity. In addition to whole cell processes, SyntheZyme combines its expertise in enzyme structure-activity relationships with immobilization technology to stabilize and activate enzymes on supports. These immobilized enzymes provide safe and sustainable biocatalytic processes for production of biobased monomers, prepolymers and surfactants. SyntheZyme biosurfactants and their derivatives are being developed to provide enhanced bioactivity. Produced by proprietary engineered yeasts and optimized by structure-activity-property relationships, they show enhanced antimicrobial and anti-aging properties suitable for applications in cosmetics and plant protection applications. Biosurfactants produced by microbes from low cost renewable feedstocks have low costs, increased safety and avoid the environmental persistence of petroleum based surfactants. SyntheZyme monomers can be polymerized to form polyhydroxyalkanoates (PHAs), a major family of polyester bioplastics. PHAs are bio-degradable, however, unlike other bioplastics, SyntheZymeâs PHAs have lower cost and greater performance control allowing the resulting plastics to be tailored for specific applications. With the flexibility to use a variety of feedstocks, SyntheZyme monomers can be used as PHA homopolymers or as a copolymers greatly expanding their range of valuable properties. PHA has an identified annual market potential of over $5 billio
